Fig. 3From: Metabolic profiling reveals metabolic features of consolidation therapy in pediatric acute lymphoblastic leukemiaMetabolomic responses to high-dose methotrexate (HDMTX) therapy in pediatric acute lymphoblastic leukemia (ALL) patients. A Heat map showing the 7 differential metabolites identified. Blue-to-red color gradient: lower to higher metabolite levels (the color represents the average normalized intensity of each metabolite). B–H Scatter plots of changes in the significantly differential metabolites before (control) and after HDMTX treatmentBack to article page